Bank of Montreal’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-29,400
Closed -$3.61M 3849
2025
Q4
$3.61M Sell
29,400
-600
-2% -$72.9K ﹤0.01% 1456
2025
Q3
$3.33M Sell
30,000
-25,000
-45% -$2.84M ﹤0.01% 1465
2025
Q2
$6.1M Hold
55,000
﹤0.01% 1168
2025
Q1
$6.16M Buy
+55,000
New +$5.68M ﹤0.01% 1101
2022
Q3
Sell
-30,000
Closed -$2.55K 4192
2022
Q2
$2.55K Buy
+30,000
New +$1.86M ﹤0.01% 1773
2021
Q3
Sell
-750,000
Closed -$63.8M 3862
2021
Q2
$63.8M Buy
+750,000
New +$50.1M 0.03% 433
2019
Q2
Sell
-35,400
Closed -$2.3M 4944
2019
Q1
$2.3M Buy
+35,400
New +$2.35M ﹤0.01% 1592
2015
Q2
Sell
-22
Closed -$2K 3998
2015
Q1
$2K Sell
22
-99,978
-100% -$10.2M ﹤0.01% 3777
2014
Q4
$9.43M Buy
+100,000
New +$10.3M 0.01% 808

Other funds holding GILD

Bank of Montreal's GILD Position: Q1 2026 in Review

Bank of Montreal increased its Gilead Sciences (GILD) stake by 2.3% in Q1 2026, buying an estimated $11.3M and bringing the position to 3,549,224 shares worth $495M. The position accounts for 0.18% of the portfolio, ranked #97.

Bank of Montreal first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $576M in Q2 2015. 2,315 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Bank of Montreal held 3,549,224 shares of Gilead Sciences worth $495M as of Q1 2026.
  • Bank of Montreal bought 80,430 Gilead Sciences shares in Q1 2026, an estimated $11.3M.
  • Gilead Sciences made up 0.18% of Bank of Montreal's portfolio in Q1 2026, its #97 holding.
  • Bank of Montreal first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
  • Bank of Montreal's Gilead Sciences position peaked at $576M in Q2 2015.
  • 2,315 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Bank of Montreal's 13F filing for Q1 2026, filed 13 May 2026.